Tanshinone IIA Protects the Heart in Diabetic Cardiomyopathy
Author Information
Author(s): Sun Dongdong, Shen Min, Li Jiayi, Li Weijie, Zhang Yingmei, Zhao Li, Zhang Zheng, Yuan Yuan, Wang Haichang, Cao Feng
Primary Institution: Fourth Military Medical University
Hypothesis
Does tanshinone IIA provide cardioprotective effects in diabetic cardiomyopathy through the kinin B2 receptor-Akt-GSK-3β signaling pathway?
Conclusion
Tanshinone IIA is cardioprotective in diabetic cardiomyopathy by inhibiting apoptosis and reducing inflammation.
Supporting Evidence
- TSN administration improved left ventricular ejection fraction in diabetic rats.
- TSN reduced myocardial apoptosis and inflammation.
- HOE140 blocked the cardioprotective effects of TSN.
Takeaway
Tanshinone IIA helps protect the heart from damage caused by diabetes, making it healthier and stronger.
Methodology
Diabetic rats were treated with tanshinone IIA and assessed for cardiac function, apoptosis, and inflammatory markers.
Limitations
The study focused only on the kinin B2 receptor-Akt-GSK-3β pathway and did not assess right ventricular function.
Participant Demographics
Sprague-Dawley rats, weight 200 to 220 g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website